Skip to content

Revvity RVTY Total debt

Total debt at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$3.06B+15.6%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
WAT
Waters CorporationWAT
Agilent Technologies logo
Agilent TechnologiesA
Illumina logo
IlluminaILMN

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Calculated from Revvity’s reported figures.

Plus components not separately reported this period.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's total debt?
Revvity (RVTY) reported total debt of $3.94B in Q1 2026.
How has Revvity's total debt changed year-over-year?
Revvity's total debt increased by 17.8% year-over-year, from $3.35B to $3.94B.
What is the long-term trend for Revvity's total debt?
Over 5 years (2020 to 2025), Revvity's total debt has grown at a 5.4% compound annual growth rate (CAGR), from $2.62B to $3.4B.
What does total debt mean?
The total amount of money the company owes to banks, bondholders, and lessors.
How do you interpret total debt?
An increase suggests higher financial leverage and potential interest expense pressure, while a decrease indicates deleveraging and reduced financial risk.
How does total debt compare across companies?
Peers in the life sciences and diagnostics sectors typically maintain debt levels aligned with their acquisition strategy and cash flow generation capacity, often measured via debt-to-EBITDA ratios.